
Impact of SLC22A1 and CYP3A5 genotypes on imatinib response in chronic myeloid leukemia: A systematic review and meta-analysis
Keywords: Chronic myeloid leukemia; Imatinib; Meta-analysis; SLC22A1; CYP3A5; Polymorphisms;